Coronary artery thrombus occurs due to rupture or erosion of preexisting coronary artery plaque, resulting in the artery's complete occlusion.  It manifests clinically as an acute coronary syndrome, including ST-elevation MI, Non-ST elevation myocardial infarction, and unstable angina. The coronary thrombus can occur in both symptomatic and asymptomatic patients with significant or less than 50% stenosis. Coronary thrombus is one of the frequent causes of sudden cardiac death. The literature review shows that coronary thrombus causes one-third of the sudden cardiac death, complete occluding the culprit artery on autopsy. The amount and duration of coronary thrombus play an essential role in determining the prognosis of ACS patients.  The coronary thrombus has a crucial impact on percutaneous coronary intervention's performance and outcome (PCI).  It is a strong predictor of PCI-induced major adverse coronary events, distal embolization, and stent thrombosis.  This chapter will review etiology, epidemiology, pathophysiology, histopathology, history and physical examination, treatment, differential diagnosis, staging, and prognosis of coronary thrombus.
The risk factors involved in coronary thrombus initiation include smoking, diabetes mellitus, hypertension, hyperlipidemia, stress, and family history of atherosclerosis.
Coronary thrombosis with acute myocardial infarction is a life-threatening condition and associated with increased morbidity and mortality globally. Coronary thrombus causes death in 200,000 persons a year in the United States, affecting males more than females
Understanding the structure of thrombus and its physical characteristics are essential to make proper treatment choices in the revascularization of atherosclerotic lesions.  Following the rupture of the plaque's fibrous cap, the internal necrotic core becomes exposed to the arterial lumen. This contact of a highly thrombogenic subendothelial matrix with the circulating platelets and white blood cells activates the coagulation cascade. It activates the platelets and promotes their adhesion and aggregation. Activated platelets release strong mediators of vasoconstriction and aggregation like serotonin, adenosine diphosphate (ADP), thromboxane A2 (TXA2), and endothelin, among others. The released tissue factor from the subendothelial matrix directly activates the extrinsic coagulation cascade and results in fibrin accumulation. All this finally accumulates to form a thrombus, which causes acute occlusion and impaired distal flow, with resultant clinical ischemic complications.  A thrombus comprises a conglomerate of platelets, red blood cells, vasoconstrictors, and procoagulant anchored to a scaffolding matrix of crisscrossing fibrin fibers. Two distinct types of branching fibrin fibers exist. The dense, thin fibers resist deforming mechanical forces and are poorly dissolve by thrombolytic agents. Thick fibrin fibers are susceptible to external mechanical forces and get dissolved by thrombolytic agents.
A thrombus comprises a conglomerate of platelets, red blood cells, vasoconstrictors, and procoagulant anchored to a scaffolding matrix of crisscrossing fibrin fibers. Two distinct types of branching fibrin fibers exist. The dense, thin fibers resist deforming mechanical forces and are poorly dissolve by thrombolytic agents. Thick fibrin fibers are susceptible to external mechanical forces and get dissolved by thrombolytic agents.
The clinical features depend on the duration and the severity of ischemia, depending on whether the obstruction is wholly or partially occlusive, transient, or persistent. Coronary artery thrombus presents clinically as sudden cardiac arrest or acute coronary syndrome.  The history may include chest pain, shortness of breath, and syncope. Sinus tachycardia is common in patients presenting with the acute coronary syndrome.  The patient may have hypotension due to low cardiac output and a poor outcome predictor. Tachypnea can occur as a result of congestive heart failure due to left ventricle dysfunction. 
On physical examination, the patient may have S4 gallop or S3 due to LV dysfunction. Heart murmurs of mitral regurgitation and ventricular septal rupture may present, especially in patients with delayed presentation. 
On laboratory tests, an elevated blood level of a cardiac enzyme (troponin)can occur in patients with coronary artery thrombus. Electrocardiogram show ST elevation in leads monitoring the artery containing thrombus. Several imaging modalities utilize for the diagnosis of intracoronary thrombus. Multiple studies have shown the low sensitivity of angiography, although specificity approaches 99-100% while using multiple angiographic views for verification.  Angiography remains the gold standard to recognize thrombus, showing the classic findings of reduced contrast density, staining, haziness, irregular lesion contour, filling defects, or a smooth convex meniscus at the site of total thrombotic occlusion. Intravascular imaging can help in conditions where the presence of coronary thrombosis is not clear. Both IVUS (Intravascular Ultrasound) and OCT (Optical coherence tomography) both can detect intracoronary thrombus. However, the sensitivity of OCT is much higher than IVUS for diagnosing intracoronary thrombus as compare to angioscopy. 
Treatment for coronary artery thrombus involves medications and revascularization to improve myocardial perfusion. The mainstay pharmacologic therapy for managing thrombus-containing lesions includes aspirin, thienopyridines (clopidogrel, prasugrel, ticagrelor), and unfractionated heparin.  But in the case of persistent thrombus, drugs such as GP IIb/IIIa inhibitors and vasodilators can help to improve epicardial and myocardial blood flow. 
Percutaneous devices such as aspiration catheter and embolic protector decrease distal embolization and improve myocardial blood flow and clinical outcomes.  Aspiration catheter manual target to lessen thrombus burden while the embolic protector target to catch the debris release during PCI.
Following the publication of several landmark studies, a rekindled interest in mechanical thrombus extraction arose, especially for STEMI management. One can categorize the contemporary mechanical thrombus removal or dissolution devices into four main types according to their activation mode: (1) manual aspiration catheters, (2) power-sourced thrombectomy, (3) ultrasound-induced sonication, and (4) embolic protection.
Manual thrombus aspiration of the infarct-related vessel is a useful method for the rapid decrease in the thrombotic burden, preventing the distal embolization of thrombus, preserving the microvascular integrity, and reducing infarct size. Manual thrombectomy, therefore, improves myocardial perfusion grade. TAPAS trial showed a mortality reduction, which led the guidelines to recommend routine manual aspiration.  However, the latest trials have shown no clear-cut benefit of routine manual aspiration in acute myocardial infarction. 
Increased thrombus burden may influence stent opposition, which can lead to low TIMI flow and poor outcomes. The best method of primary percutaneous intervention in the setting of coronary thrombus has been reported in the SINCERE database.  According to it, if the thrombus size is small, direct stenting may be adequate. If the thrombus burden is more, it is wise to perform aspiration thrombectomy before stenting to minimize distal embolization and no-reflow. If the thrombus burden is vast, then more aggressive thrombectomy devices such as Angio jet Rt are better to remove thrombus.
The differential diagnoses based on symptoms include pulmonary embolism, acute peptic ulcer, pericarditis, and herpes zoster.
The differential diagnoses based on angiography include coronary artery dissection, coronary calcification, and no-reflow phenomenon.
Grading systems are essential for the adequate assessment of thrombus burden to assist management decisions before and during interventions. The TIMI Study Group introduced the most commonly used thrombus grading classification. Their method based on a visual angiographic assessment of the thrombus size using a score that ranges from grade 0 to grade 5. 
The existence of coronary thrombus on angiogram is a negative predictor associated with higher MACE (Major adverse cardiovascular events).  The coronary thrombus can occlude the coronary artery and its branches, resulting in an impairment of epicardial and myocardial blood flow. The thrombus size and consistency are also important prognostic markers of distal embolization. Multiple studies have shown that distal embolization is associated with an increase in mortality.
Complications associated with coronary thrombus include sudden cardiac death, congestive heart failure, and cardioembolic stroke.
The following persons should involve in patients with coronary thrombus:
The cardiac team should explain to patients to come to the emergency department as early as possible if symptoms such as chest pain and shortness of breath develop. Besides, they should:
Thrombus plays a significant role in the pathophysiology of acute coronary syndromes (ACS). The formation of a thrombus within a coronary artery with obstruction of coronary blood flow and reduction in oxygen supply to the myocardium produces several ACS. It is essential to understand the structural components and burden of the thrombus to decide revascularization strategies. Strategies combining dietary, pharmacologic-medical, and interventional-surgical therapies have shown considerable success in preventing and treating major cardiovascular events. These regimens focus on inhibiting the various pathways involved in thrombus generation. Novel strategies based on the knowledge of platelet aggregation's biochemistry and the coagulation processes and the geometric conditions encountered in the circulation are in different stages of development and clinical trials. Advances in noninvasive imaging techniques will help identify plaques at risk and reduce thrombosis's clinical impact.
Many interventional cardiologists widely practice thrombus aspiration during percutaneous coronary intervention in a STEMI patient. (Level II) However, recent trials (TASTE and TOTAL) have raised doubts over its value and safety. As a result, the current guidelines do not recommend the routine use of thrombus aspiration in STEMI patients. (Level III)
|||Davies MJ,Thomas A, Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. The New England journal of medicine. 1984 May 3 [PubMed PMID: 6709008]|
|||Vukovich RA,Willard DA,Brannick LJ, Endocrine and cardiovascular consequences of angiotensin converting enzyme inhibition. The Journal of international medical research. 1977 [PubMed PMID: 190063]|
|||Cobbe SM, Sudden cardiac death and acute coronary thrombosis. British medical journal (Clinical research ed.). 1985 Jan 12 [PubMed PMID: 3917736]|
|||Virmani R,Burke AP,Farb A, Sudden cardiac death. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology. 2001 Sep-Oct [PubMed PMID: 11673058]|
|||Sianos G,Papafaklis MI,Daemen J,Vaina S,van Mieghem CA,van Domburg RT,Michalis LK,Serruys PW, Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. Journal of the American College of Cardiology. 2007 Aug 14 [PubMed PMID: 17692740]|
|||Singh M,Berger PB,Ting HH,Rihal CS,Wilson SH,Lennon RJ,Reeder GS,Bresnahan JF,Holmes DR Jr, Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience). The American journal of cardiology. 2001 Nov 15 [PubMed PMID: 11703950]|
|||Ferreira JA,Gonçalves L,Naghipoor J,de Oliveira P,Rabczuk T, The effect of plaque eccentricity on blood hemodynamics and drug release in a stented artery. Medical engineering [PubMed PMID: 30111489]|
|||Mahajan K,Negi PC,Merwaha R,Mahajan N,Chauhan V,Asotra S, Gender differences in the management of acute coronary syndrome patients: One year results from HPIAR (HP-India ACS Registry). International journal of cardiology. 2017 Dec 1 [PubMed PMID: 28942868]|
|||Mahajan K,Batra A,Gupta A,Singla V, Multiple distal coronary artery thrombosis in acute myocardial infarction: a rare presentation. BMJ case reports. 2018 Jul 24 [PubMed PMID: 30042110]|
|||Huang J,Belmadani K,Chatot M,Ecarnot F,Chopard R,Wang M,Cai X,Schiele F,Meneveau N, Clinical significance of optical coherence tomography-guided angioplasty on treatment selection. Experimental and therapeutic medicine. 2018 Aug [PubMed PMID: 30116307]|
|||Rakic M,Persic V,Kehler T,Bastiancic AL,Rosovic I,Laskarin G,Sotosek Tokmadzic V, Possible role of circulating endothelial cells in patients after acute myocardial infarction. Medical hypotheses. 2018 Aug [PubMed PMID: 30077195]|
|||Hannawi B,Hannawi Y,Kleiman NS, Reticulated Platelets: Changing Focus from Basics to Outcomes. Thrombosis and haemostasis. 2018 Aug 13 [PubMed PMID: 30103247]|
|||Armstrong EJ,Feldman DN,Wang TY,Kaltenbach LA,Yeo KK,Wong SC,Spertus J,Shaw RE,Minutello RM,Moussa I,Ho KK,Rogers JH,Shunk KA, Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC. Cardiovascular interventions. 2012 Feb [PubMed PMID: 22361596]|
|||Ahmed AM,Abdulwahab AM,Hesham AF,Nawar W, Clinical Presentation, Management and Outcome of Acute Coronary Syndrome in Yemen: Data from GULF RACE - 2 Registry. Heart views : the official journal of the Gulf Heart Association. 2013 Oct [PubMed PMID: 24695681]|
|||Falk E, Coronary thrombosis: pathogenesis and clinical manifestations. The American journal of cardiology. 1991 Sep 3 [PubMed PMID: 1892065]|
|||Dezman ZD,Mattu A,Body R, Utility of the History and Physical Examination in the Detection of Acute Coronary Syndromes in Emergency Department Patients. The western journal of emergency medicine. 2017 Jun [PubMed PMID: 28611898]|
|||Amraotkar AR,Ghafghazi S,Trainor PJ,Hargis CW,Irfan AB,Rai SN,Bhatnagar A,DeFilippis AP, Presence of multiple coronary angiographic characteristics for the diagnosis of acute coronary thrombus. Cardiology journal. 2017 [PubMed PMID: 28150291]|
|||Kubo T,Imanishi T,Takarada S,Kuroi A,Ueno S,Yamano T,Tanimoto T,Matsuo Y,Masho T,Kitabata H,Tsuda K,Tomobuchi Y,Akasaka T, Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. Journal of the American College of Cardiology. 2007 Sep 4 [PubMed PMID: 17765119]|
|||Van de Werf F,Bax J,Betriu A,Blomstrom-Lundqvist C,Crea F,Falk V,Filippatos G,Fox K,Huber K,Kastrati A,Rosengren A,Steg PG,Tubaro M,Verheugt F,Weidinger F,Weis M, Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. European heart journal. 2008 Dec [PubMed PMID: 19004841]|
|||O'Gara PT,Kushner FG,Ascheim DD,Casey DE Jr,Chung MK,de Lemos JA,Ettinger SM,Fang JC,Fesmire FM,Franklin BA,Granger CB,Krumholz HM,Linderbaum JA,Morrow DA,Newby LK,Ornato JP,Ou N,Radford MJ,Tamis-Holland JE,Tommaso JE,Tracy CM,Woo YJ,Zhao DX, 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Jan 29 [PubMed PMID: 23247303]|
|||Neumann FJ,Blasini R,Schmitt C,Alt E,Dirschinger J,Gawaz M,Kastrati A,Schömig A, Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation. 1998 Dec 15 [PubMed PMID: 9851955]|
|||Micari A,Belcik TA,Balcells EA,Powers E,Wei K,Kaul S,Lindner JR, Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting. The American journal of cardiology. 2005 Nov 15 [PubMed PMID: 16275189]|
|||Svilaas T,Vlaar PJ,van der Horst IC,Diercks GF,de Smet BJ,van den Heuvel AF,Anthonio RL,Jessurun GA,Tan ES,Suurmeijer AJ,Zijlstra F, Thrombus aspiration during primary percutaneous coronary intervention. The New England journal of medicine. 2008 Feb 7 [PubMed PMID: 18256391]|
|||Napodano M,Pasquetto G,Saccà S,Cernetti C,Scarabeo V,Pascotto P,Reimers B, Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. Journal of the American College of Cardiology. 2003 Oct 15 [PubMed PMID: 14563581]|
|||Hizoh I,Banhegyi G,Domokos D,Gulyas Z,Major L,Kiss RG, Impact of Selective Aspiration Thrombectomy on Mortality in Patients With ST-Segment Elevation Myocardial Infarction. The American journal of cardiology. 2018 Apr 1 [PubMed PMID: 29397104]|
|||Marmagkiolis K,Feldman DN,Charitakis K, Thrombus Aspiration in STEMI. Current treatment options in cardiovascular medicine. 2016 Jan [PubMed PMID: 26780331]|
|||Taglieri N,Bacchi Reggiani ML,Ghetti G,Saia F,Compagnone M,Lanati G,Di Dio MT,Bruno A,Bruno M,Della Riva D,Corsini A,Narducci R,Rapezzi C, Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials. European heart journal. Acute cardiovascular care. 2018 Aug 30 [PubMed PMID: 30160519]|
|||Vecchio S,Varani E,Chechi T,Balducelli M,Vecchi G,Aquilina M,Ricci Lucchi G,Dal Monte A,Margheri M, Coronary thrombus in patients undergoing primary PCI for STEMI: Prognostic significance and management. World journal of cardiology. 2014 Jun 26 [PubMed PMID: 24976910]|
|||Gibson CM,de Lemos JA,Murphy SA,Marble SJ,McCabe CH,Cannon CP,Antman EM,Braunwald E, Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001 May 29 [PubMed PMID: 11382722]|
|||Tanboga IH,Topcu S,Aksakal E,Kalkan K,Sevimli S,Acikel M, Determinants of angiographic thrombus burden in patients with ST-segment elevation myocardial infarction. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2014 Oct [PubMed PMID: 23539672]|